Olhar Digital reports a Chinese approval for Wegovy, Novo Nordisk's semaglutide shot for weight loss. Few details beyond the headline were given.
Recap by typeshit. Full story at Olhar Digital.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
King Khalid University researchers also report substantial weight regain after people stop the drug, and flag gallbladder and retinopathy signals worth watching.
A general drug reference post pointing to tirzepatide basics like interactions and warnings. Evergreen material with no new development behind it.
Loading…